Current status of hepatic resection for hepatocellular carcinoma

被引：41

作者：

Yanaga, K ^{[1
]}

机构：

[1] Jikei Univ, Dept Surg, Sch Med, Minato Ku, Tokyo 1058461, Japan

来源：

JOURNAL OF GASTROENTEROLOGY | 2004年 / 39卷 / 10期

关键词：

hepatocellular carcinoma; hepatic resection;

D O I：

10.1007/s00535-004-1422-x

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Hepatocellular carcinoma (HCC) is one of the most common tumors worldwide. For this disease, a variety of therapeutic measures have been applied, including hepatic resections, total hepatectomy followed by allografting, transarterial chemoembolization, and percutaneous tumor ablative therapy by ethanol, microwave coagulation, and radiofrequency ablation. This article focuses on the current status of hepatic resections for HCC.

引用

页码：919 / 926

页数：8

共 82 条

[1] RISK-FACTORS FOR INTRAHEPATIC RECURRENCE IN HUMAN SMALL HEPATOCELLULAR-CARCINOMA [J].

ADACHI, E ;

MAEDA, T ;

MATSUMATA, T ;

SHIRABE, K ;

KINUKAWA, N ;

SUGIMACHI, K ;

TSUNEYOSHI, M .

GASTROENTEROLOGY, 1995, 108 (03) :768-775

[2]

Arii S, 1998, J Hepatobiliary Pancreat Surg, V5, P86, DOI 10.1007/PL00009956

[3] Underlying liver disease, not tumor factors, predicts long-term survival alter resection of hepatocellular carcinoma [J].

Bilimoria, MM ;

Lauwers, GY ;

Doherty, DA ;

Nagorncy, DM ;

Belghiti, J ;

Do, KA ;

Regimbeau, JM ;

Ellis, LM ;

Curley, SA ;

Ikai, I ;

Yamaoka, Y ;

Vauthey, JN .

ARCHIVES OF SURGERY, 2001, 136 (05) :528-534

[4] Serum interleukin-10 but not interleukin-6 is related to clinical outcome in patients with resectable hepatocellular carcinoma [J].

Chau, GY ;

Wu, CW ;

Lui, WY ;

Chang, TJ ;

Kao, HL ;

Wu, LH ;

King, KL ;

Loong, CC ;

Hsia, CY ;

Chi, CW .

ANNALS OF SURGERY, 2000, 231 (04) :552-558

[5]

CHIU JH, 1993, HEPATOLOGY, V18, P96, DOI 10.1002/hep.1840180116

[6] High rates of hepatocellular carcinoma in cirrhotic patients with high liver cell proliferative activity [J].

Donato, MF ;

Arosio, E ;

Del Ninno, E ;

Ronchi, G ;

Lampertico, P ;

Morabito, A ;

Balestrieri, MR ;

Colombo, M .

HEPATOLOGY, 2001, 34 (03) :523-528

[7] The lidocaine (MEGX) test as an index of hepatic function:: Its clinical usefulness in liver surgery [J].

Ercolani, G ;

Grazi, GL ;

Callivà, R ;

Pierangeli, F ;

Cescon, M ;

Cavallari, A ;

Mazziotti, A .

SURGERY, 2000, 127 (04) :464-471

[8] Hepatectomy for hepatocellular carcinoma: Toward zero hospital deaths [J].

Fan, ST ;

Lo, CM ;

Liu, CL ;

Lam, CM ;

Yuen, WK ;

Yeung, C ;

Wong, J .

ANNALS OF SURGERY, 1999, 229 (03) :322-330

[9] An analysis of 412 cases of hepatocellular carcinoma at a western center [J].

Fong, YM ;

Sun, RL ;

Jarnagin, W ;

Blumgart, LH .

ANNALS OF SURGERY, 1999, 229 (06) :790-799

[10] Improved results of liver resection for hepatocellular carcinoma on cirrhosis give the procedure added value [J].

Grazi, GL ;

Ercolani, G ;

Pierangeli, F ;

Del Gaudio, M ;

Cescon, M ;

Cavallari, A ;

Mazziotti, A .

ANNALS OF SURGERY, 2001, 234 (01) :71-78

← 1 2 3 4 5 6 7 8 9 →